https://assets.realclear.com/images/67/674458_1_.jpeg
The Trump administration recently released an executive order directing Medicare and Medicaid drug reimbursement to be based on prices in other countries, using a model called Most Favored Nation (MFN) pricing. While this may sound good, a less flattering name could be the Most Dictatorial Nation model, as other nations’ prices are set by government dictate, not a competitive market. The truth is that MFN is a shortcut to drug shortages, delayed innovation, higher prices, and administrative gamesmanship in the 340B drug pricing program.
About Author
This post was originally published on this site
